期刊
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
卷 25, 期 3, 页码 597-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.iac.2005.06.001
关键词
-
Asthma and allergic rhinitis are both characterized by airway inflammation, and glucocorticosteroids form the cornerstone of their pharmacologic treatment. All patients with asthma should be prescribed rapid-acting inhaled beta(2)-agonists as needed to use as rescue therapy in case of symptoms. As soon as patients experience symptoms at least once a week, controller medications should be started on a daily basis to achieve and maintain control of their asthma. Intranasal corticosteroids are given as first-line therapy for moderate to severe persistent rhinitis. Depending on the dominant symptom, H(1)-antihistamines, decongestants, or ipratropium can be added after re-evaluation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据